50% off Premium Yearly

NASDAQ:MEDP
Medpace Holdings is a American stock, trading under the symbol MEDP (previously MEDP-Q on Stockchase) on the NASDAQ (MEDP). It is usually referred to as NASDAQ:MEDP or MEDP
In the last year, no analyst issued a Buy, Sell, or Hold rating on MEDP (previously MEDP-Q on Stockchase) on Stockchase. Read the latest expert commentary for Medpace Holdings.
Medpace Holdings was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Medpace Holdings.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Medpace Holdings.
Medpace Holdings is covered by Stockchase experts and is worth watching.
On 2026-06-18, Medpace Holdings (MEDP) stock closed at a price of $460.24.
MEDP is a clinical research company that helps smaller biotechs perform research and navigate/move along the pathway to commercialization. They tend to focus on smaller companies, so they tend to feel the booms and busts a bit more than peers but we view it as a solid company that has navigated the last few years well. Fundamentals are quite strong as well and the growth on the top-line is solid in the 15% range over the next two years expected. We think the big question comes down to valuation at 30X forward earnings. We would be comfortable buying it based on the outlook for its earnings and interest rates.
Unlock Premium - Try 5i Free